West Pharmaceutical Services Reports Strong Q2 Performance

1 Mins read

West Pharmaceutical Services, a pharmaceutical company based in Exton, PA, has surpassed expectations with its second-quarter profit despite a predicted decline in Covid-19 revenue. The company’s performance has led to an upward revision of its full-year guidance.

Earnings for the second quarter totaled $155 million, or $2.06 per share, compared to $189 million, or $2.48 per share, in the same period last year. Analysts had anticipated earnings of $1.89 per share, according to FactSet’s polls. Adjusted for certain one-time items, West reported earnings of $2.11 per share, exceeding analyst expectations of $1.93 per share.

However, sales saw a slight decline of 2.3%, reaching $754 million, falling short of the anticipated $756 million projected by analysts. When adjusting for the impact of foreign currency and acquisitions and divestitures, organic sales dropped by 2.5%. On the bright side, the contract-manufactured product segment experienced a 15% increase, primarily driven by robust sales growth in components associated with injection-related devices.

Unfortunately, West pharmaceuticals witnessed a 5.5% decline in sales for its proprietary products segments due to decreased revenue from Covid-19 related items.

Despite these challenges, the company remains optimistic about its future prospects and has raised its full-year adjusted earnings per share and net sales guidance in light of its impressive second-quarter performance.

Contact us for more information.

Related posts

Banking Regulations for Preventing Failures

2 Mins read
Banking regulators have the power to prevent future bank collapses, according to a panel of banking experts who emphasized the importance of…

Dave's Strong Q4 Performance

1 Mins read
Shares of Dave surged on Tuesday following the digital bank’s announcement of a profitable fourth quarter earlier than expected, with a positive…

DaVita Expands in Latin America

1 Mins read
Shares of DaVita reached record levels as the kidney care services company announced its significant expansion into Latin America through a $300…

Leave a Reply

Your email address will not be published. Required fields are marked *

67 − = 59